Equity Research, Broker Reports, and media content on Cosmo Pharmaceuticals NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Cosmo Pharmaceuticals NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Cosmo Pharmaceuticals NV

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Cosmo Pharmaceuticals NV. We currently have 0 research reports from 1 professional analysts.

Date Source Announcement
06Dec23 06:00 EQS-News Cosmo bestätigt vollständige Rückzahlung in bar von EUR 175 Mio. Wandelanleihen
06Dec23 06:00 DGAP-News Cosmo confirms full redemption in cash of €175m Convertible Bonds
10Oct23 06:00 EQS-News Cosmo reicht Zulassungsantrag für Winlevi® bei der Europäischen Arzneimittel-Agentur (EMA) ein
10Oct23 06:00 DGAP-News Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)
02Oct23 06:00 EQS-News Cosmo und Hikma unterzeichnen Lizenzvertrag für Winlevi® in 17 Ländern des Nahen Ostens und Nordafrika
02Oct23 06:00 DGAP-News Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries
27Sep23 06:00 DGAP-AHD Cosmo und Glenmark geben die Unterzeichnung von Vertriebs- und Lizenzvereinbarungen für Winlevi® in Europa und Südafrika bekannt
  • Frequency of research reports

     

  • Research reports on

    Cosmo Pharmaceuticals NV

  • Providers covering

    Cosmo Pharmaceuticals NV

Frequently asked questions